Viz.ai

Health & BioTech Dual-Use Technology Investment Opportunity Founded 2016

AI-powered healthcare platform that automatically detects critical conditions from medical imaging and accelerates care coordination across health systems.

Visit Website

Company Overview

Viz.ai is an Israeli-American healthcare AI company founded in 2016 that uses artificial intelligence to detect time-sensitive medical conditions from imaging scans. The platform automatically analyzes CT scans, ECGs, and other medical data to identify conditions like stroke, pulmonary embolism, and aortic disease, alerting specialists immediately.

The company's FDA-cleared algorithms have been proven to reduce time-to-treatment for critical conditions, directly impacting patient outcomes. Viz.ai's care coordination platform connects radiologists, neurologists, cardiologists, and other specialists for rapid intervention.

Viz.ai has raised over $250 million in funding and serves hundreds of health systems across the United States. The platform processes millions of scans annually, demonstrating AI's potential to save lives through faster detection and treatment.

Dual-Use Assessment

Medical AI and rapid diagnostic capabilities have dual-use applications for military medicine, casualty care, and field hospital operations where fast diagnosis is critical.

Key Technologies

  • Medical imaging AI
  • FDA-cleared diagnostic algorithms
  • Care coordination platform
  • Real-time alerting
  • Clinical workflow integration

Use Cases & Applications

  • Stroke detection and triage
  • Cardiac emergency identification
  • Pulmonary embolism detection
  • Aortic disease identification
  • Military medical triage

Strategic Value to U.S.-Israel Alliance

Rapid medical diagnosis capabilities support military medicine and casualty care for allied forces. AI-powered triage can save lives in combat situations.

Interested in this startup?

Learn more about our investment approach or get in touch to discuss opportunities in dual-use technology.